30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Dan Brennan

Insider profile

Currently holds positions in Boston Scientific Corp and Nuance Communications Inc

Performance

Overall performance
0.8

Performance over holding periods
0.8
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Chief Financial Officer, Executive Vice President Boston Scientific Corp Jan. 1, 2014 -
Independent Director Nuance Communications Inc Sept. 10, 2018 -

Dan Brennan's trades of Boston Scientific Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-02-19 2025-02-19 PrS Proposed sale
6,353
436.84
US$2,971,318
6,353 436.84 US$2,971,318
2025-02-19 2025-02-19 PlS Planned sale
78,234 +40.5%
163.22
US$754,650
78,234 +40.5% 163.22 US$754,650
2025-02-19 2025-02-18 PlS Planned sale
5,760 +0.3%
145.21
US$970,243
5,760 +0.3% 145.21 US$970,243
2025-02-19 2025-02-18 PlS Planned sale
2,900 -1.2%
104.08
US$301,818
2,900 -1.2% 104.08 US$301,818
2025-02-18 2025-02-18 PrS Proposed sale
17,530
104.57
US$1,833,184
17,530 104.57 US$1,833,184
2025-02-13 2025-02-12 PlS Planned sale
15,087 -5.9%
105.07
US$1,585,135
15,087 -5.9% 105.07 US$1,585,135
2025-02-12 2025-02-12 PrS Proposed sale
15,087
105.07
US$1,585,135
15,087 105.07 US$1,585,135
2025-01-03 2025-01-03 PrS Proposed sale
9,689
89.86
US$870,635
9,689 89.86 US$870,635
2025-01-03 2025-01-03 PlS Planned sale
9,689 -4.1%
89.86
US$870,636
9,689 -4.1% 89.86 US$870,636
2024-05-23 2024-05-23 PrS Proposed sale
47,621
75.11
US$3,576,928
47,621 75.11 US$3,576,928
2024-05-23 2024-05-23 PlS Planned sale
47,621 -17.5%
75.11
US$3,576,932
47,621 -17.5% 75.11 US$3,576,932
2024-05-23 2024-05-22 PlS Planned sale
64,454 -19.2%
75.91
US$4,892,819
64,454 -19.2% 75.91 US$4,892,819
2024-05-22 2024-05-22 PrS Proposed sale
64,454
75.91
US$4,892,813
64,454 75.91 US$4,892,813
2024-02-20 2024-02-20 PrS Proposed sale
13,662
65.86
US$899,779
13,662 65.86 US$899,779
2024-02-20 2024-02-20 S Sale
13,662 -4.8%
65.86
US$899,779
13,662 -4.8% 65.86 US$899,779
2023-03-02 2023-03-02 PlS Planned sale
30,000 -11.7%
46.66
US$1,399,914
30,000 -11.7% 46.66 US$1,399,914
2023-03-02 2023-03-01 PlS Planned sale
75,610 -22.8%
46.64
US$3,526,337
75,610 -22.8% 46.64 US$3,526,337
2023-02-16 2023-02-15 PlS Planned sale
7,572 -2.7%
47.14
US$356,927
7,572 -2.7% 47.14 US$356,927
2022-03-03 2022-03-02 PlS Planned sale
11,029 -4.0%
44.03
US$485,650
11,029 -4.0% 44.03 US$485,650
2022-02-24 2022-02-22 PlS Planned sale
53,182 -16.3%
42.75
US$2,273,621
53,182 -16.3% 42.75 US$2,273,621
2022-02-17 2022-02-16 PlS Planned sale
12,187 -4.4%
43.70
US$532,580
12,187 -4.4% 43.70 US$532,580
2022-02-17 2022-02-15 PlS Planned sale
9,136 -3.3%
43.47
US$397,142
9,136 -3.3% 43.47 US$397,142
2021-03-04 2021-03-03 PlS Planned sale
12,127 -4.4%
38.69
US$469,177
12,127 -4.4% 38.69 US$469,177
2021-03-04 2021-03-02 PlS Planned sale
9,475 -3.3%
38.84
US$368,034
9,475 -3.3% 38.84 US$368,034
2021-02-24 2021-02-23 PlS Planned sale
24,846 -8.1%
39.23
US$974,704
24,846 -8.1% 39.23 US$974,704
2021-01-06 2021-01-05 PlS Planned sale
17,083 -6.1%
35.32
US$603,407
17,083 -6.1% 35.32 US$603,407
2020-02-13 2020-02-13 PlS Planned sale
20,463 -8.2%
42.03
US$860,041
20,463 -8.2% 42.03 US$860,041
2019-10-03 2019-10-02 PlS Planned sale
20,462 -8.7%
39.44
US$807,040
20,462 -8.7% 39.44 US$807,040
2019-03-15 2019-03-14 PlS Planned sale
46,360 -17.7%
40.02
US$1,855,545
46,360 -17.7% 40.02 US$1,855,545
2019-03-05 2019-03-04 PlS Planned sale
64,223 -19.7%
40.84
US$2,622,553
64,223 -19.7% 40.84 US$2,622,553
2019-02-19 2019-02-14 PlS Planned sale
22,438 -7.4%
39.57
US$887,912
22,438 -7.4% 39.57 US$887,912